A review of the clinical, radiological and biochemical characteristics and genetic causes of high bone mass disorders.
CONCLUSION: The clarification of the etiologies of HBM may have a breakthrough role in understanding the molecular mechanisms involved in bone metabolism and may provide new pathways for the intervention of osteoporosis.
PMID: 29359663 [PubMed - as supplied by publisher]
Source: Current Drug Targets - Category: Drugs & Pharmacology Authors: Chen X, Yu H, Yu X Tags: Curr Drug Targets Source Type: research
More News: Drugs & Pharmacology | Genetics | Hepatitis | Hepatitis C | Orthopaedics | Osteoporosis | Radiography